Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
mRNA-3927 si inserisce strategicamente nel portafoglio delle malattie rare metaboliche di Recordati La collaborazione unisce l’expertise di Moderna nella tecnologia mRNA per i disturbi metabolicirari...
-
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
-
BANNOCKBURN, Ill., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion...
-
GERMANTOWN, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable...
-
NUTRAHARMONY releases new research guide exploring how consumers assess beet root extract supplements in 2026, with a focus on transparency standards.
-
Wayne, PA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- TekniPlex, a global leader in engineered sealing and material science solutions, will unveil a portfolio of next-generation sealing innovations at Paris...
-
MONTRÉAL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, today released healthcare-specific insights from its 2026 State...
-
PHILADELPHIA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- NBME announced the availability of its Communication Learning Assessment (CLA), which is designed to help medical students practice and develop...
-
Long Beach, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The announcement by a former US Senator of a “Death Sentence” because of his diagnosis of pancreatic cancer has drawn increased attention to this...
-
This buyer’s guide explains how consumers evaluate glucosamine supplements for joints based on ingredient quality and routine compatibility.